Skip to Content

Seven Must-Read Stories (Week Ending January 17, 2014)

Another chance to catch the most interesting, and important, articles from the previous week on MIT Technology Review.
  1. Printed Eye Cells Could Help Treat Blindness
    The ability to print retinal cells could lead to new therapies for retinal disorders such as macular degeneration.
  2. Net Neutrality Quashed: New Pricing Schemes, Throttling, and Business Models to Follow
    A court loss for “net neutrality” could mean either a new era of innovation or preferential treatment and higher costs.
  3. Tesla Motors’ Over-the-Air Repairs Are the Way Forward
    Tesla and GM have both issued fire-related recalls, but Tesla’s fix doesn’t require owners to bring their cars in.
  4. How the Friendship Paradox Makes Your Friends Better Than You Are
    The friendship paradox is the empirical observation that your friends have more friends than you do. Now network scientists say your friends are probably wealthier and happier, too.
  5. Chasing the Dream of Half-Price Gasoline from Natural Gas
    A startup called Siluria thinks it’s solved a mystery that has stymied huge oil companies for decades.
  6. Does Illumina Have the First $1,000 Genome?
    Illumina announces a new high-end sequencer made for “factory-scale” sequencing of human genomes.
  7. Experimental Surgery Aims to Revive a Paralyzed Limb
    A paralyzed man will receive experimental surgery connecting a brain chip to systems that activate muscles in his arm.
  8. <

Keep Reading

Most Popular

The inside story of how ChatGPT was built from the people who made it

Exclusive conversations that take us behind the scenes of a cultural phenomenon.

How Rust went from a side project to the world’s most-loved programming language

For decades, coders wrote critical systems in C and C++. Now they turn to Rust.

Design thinking was supposed to fix the world. Where did it go wrong?

An approach that promised to democratize design may have done the opposite.

Sam Altman invested $180 million into a company trying to delay death

Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.